Published in Mediators Inflamm on January 01, 2008
White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica (2011) 1.32
White blood cell count in women: relation to inflammatory biomarkers, haematological profiles, visceral adiposity, and other cardiovascular risk factors. J Health Popul Nutr (2013) 0.94
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90
Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice. Cytokine (2011) 0.88
Relationship between lipid and hematological profiles with adiposity in obese adolescents. Rev Bras Hematol Hemoter (2013) 0.83
Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects. BMC Cardiovasc Disord (2014) 0.83
Effects of lead exposure on the status of platelet indices in workers involved in a lead-acid battery manufacturing plant. J Expo Sci Environ Epidemiol (2014) 0.79
Cardiovascular correlates of platelet count and volume in the Framingham Heart Study. Ann Epidemiol (2015) 0.78
Platelet counts and liver enzymes after bariatric surgery. J Obes (2013) 0.78
Metabolic effects of Roux-en-Y gastric bypass in obese adolescents and young adults. J Pediatr Gastroenterol Nutr (2013) 0.78
Expression of plasma membrane receptor genes during megakaryocyte development. Physiol Genomics (2013) 0.77
Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study. Biomark Med (2016) 0.75
Platelet activity and cardiovascular risk in obesity and obstructive sleep apnea: compelling need for interdisciplinary research? J Clin Sleep Med (2011) 0.75
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases. Front Genet (2016) 0.75
Relevance of Haematologic Parameters in Obese Women with or without Metabolic Syndrome. J Clin Diagn Res (2016) 0.75
Plasma markers of inflammation and hemostatic and endothelial activity in naturally overweight and obese dogs. BMC Vet Res (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation (2004) 20.67
Elevated C-reactive protein levels in overweight and obese adults. JAMA (1999) 9.94
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis (2000) 4.88
American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. Circulation (1998) 2.84
Platelet activation in obese women: role of inflammation and oxidant stress. JAMA (2002) 2.79
Thrombogenesis in sickle cell disease. J Lab Clin Med (2001) 2.75
Influence of obesity on immune function. J Am Diet Assoc (1999) 2.42
Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem (1999) 2.35
Course of platelet activation markers after ischemic stroke. Stroke (2002) 2.05
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol (2006) 1.58
Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) (1985) 1.42
Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J Clin Invest (2001) 1.41
Review article: platelets in inflammatory bowel disease--pathogenetic role and therapeutic implications. Aliment Pharmacol Ther (1997) 1.26
Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1992) 1.21
Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes (1999) 1.15
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost (2006) 1.01
Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost (2001) 1.00
Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood (1998) 0.91
Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb (1992) 0.88
Increased platelet count and leucocyte-platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis. J Neurol Neurosurg Psychiatry (2005) 0.87
Interleukin-6 and megakaryocytopoiesis: an update. Ann Hematol (1996) 0.85
sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis (2007) 0.84
Gender differences in platelet count and its association with cigarette smoking in a large cohort in Israel. J Clin Epidemiol (1992) 0.84
Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells. Haematologica (2000) 0.81
Beta-thromboglobulin and platelet counts - effect of malignancy, infection, age and obesity. Thromb Res (1982) 0.79
Clinical significance of beta-thromboglobulin in patients with high platelet count. Acta Haematol (1984) 0.78
Altered properties of platelet membrane in childhood obesity. Biochem Int (1988) 0.78
The plasma levels of soluble P-selectin in subjects with prediabetes. Int J Clin Pract (2006) 0.78
The effect of platelet number and haematocrit on whole blood thromboxane synthesis. Thromb Haemost (1985) 0.77
No evidence of platelet activation in obesity. Thromb Haemost (1993) 0.77
Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death proven fact or wishful thinking? J Am Coll Cardiol (2011) 3.86
Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis (2012) 2.38
Megakaryocyte development and platelet production. Br J Haematol (2006) 2.02
Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01
Erythrocyte aggregation as a cause of slow flow in patients of acute coronary syndromes. Int J Cardiol (2011) 1.94
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood (2003) 1.92
Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm (2004) 1.86
Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors. Medicine (Baltimore) (2003) 1.78
The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol (2007) 1.69
Characterization of normocalcemic primary hyperparathyroidism. Am J Med (2004) 1.69
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Provocation of sudden heart rate oscillation with adenosine exposes abnormal QT responses in patients with long QT syndrome: a bedside test for diagnosing long QT syndrome. Eur Heart J (2005) 1.61
Diagnostic yield of extensive infectious panel testing in acute pericarditis. Cardiology (2011) 1.55
Burnout and risk of type 2 diabetes: a prospective study of apparently healthy employed persons. Psychosom Med (2006) 1.52
Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol (2013) 1.52
Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med (2002) 1.51
Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol (2007) 1.50
Cardiovascular risk factors in men with ischemic heart disease and erectile dysfunction. Urology (2013) 1.47
Asthma in adventure travelers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Arch Intern Med (2002) 1.45
The "short-coupled" variant of right ventricular outflow ventricular tachycardia: a not-so-benign form of benign ventricular tachycardia? J Cardiovasc Electrophysiol (2005) 1.44
Radiofrequency ablation of atrioventricular nodal reentry tachycardia: a 14 year experience with 901 patients at the Tel Aviv Sourasky Medical Center. Isr Med Assoc J (2006) 1.42
Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost. J Clin Hypertens (Greenwich) (2006) 1.41
Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels. Clin Biochem (2012) 1.39
The prevalence of reversible cardiovascular risk factors in Israelis aged 25-55 years. Isr Med Assoc J (2006) 1.38
The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol (2005) 1.31
Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol (2004) 1.28
Surgery for sporadic abdominal desmoid tumor: is low/no recurrence an achievable goal? Isr Med Assoc J (2009) 1.25
Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis (2003) 1.22
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol (2006) 1.20
Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm (2007) 1.20
H1N1 influenza: initial chest radiographic findings in helping predict patient outcome. Radiology (2010) 1.20
Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum (2006) 1.17
On the nature of burnout-insomnia relationships: a prospective study of employed adults. J Psychosom Res (2008) 1.16
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Idiopathic intracranial hypertension is associated with lower body adiposity. Ophthalmology (2009) 1.07
Revascularization of the right coronary artery in bilateral internal thoracic artery grafting. Ann Thorac Surg (2005) 1.06
Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes? J Electrocardiol (2009) 1.04
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04
Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease. J Am Coll Cardiol (2011) 1.03
Incidence of cytomegalovirus-associated thrombosis and its risk factors: a case-control study. Thromb Res (2010) 1.03
Platelet inhibitory effect of clopidogrel in patients treated with omeprazole, pantoprazole, and famotidine: a prospective, randomized, crossover study. Clin Cardiol (2013) 1.02
Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01
Burnout and risk of coronary heart disease: a prospective study of 8838 employees. Psychosom Med (2012) 0.97
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
First report of metronidazole-induced QT interval prolongation. Int J Antimicrob Agents (2007) 0.95
Thrombophilic factors in idiopathic intracranial hypertension: a report of 51 patients and a meta-analysis. Blood Coagul Fibrinolysis (2010) 0.95
Cholinesterases as biomarkers for parasympathetic dysfunction and inflammation-related disease. J Mol Neurosci (2013) 0.93
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res (2006) 0.93
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol (2010) 0.92
Prevalence of erectile dysfunction among young adults: results of a large-scale survey. J Sex Med (2004) 0.92
Drug-induced torsades de pointes in patients aged 80 years or more. Anadolu Kardiyol Derg (2008) 0.92
Erectile dysfunction might be associated with chronic periodontal disease: two ends of the cardiovascular spectrum. J Sex Med (2008) 0.91
Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism (2009) 0.91
Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res (2007) 0.91
Radiofrequency ablation of accessory pathways: a 14 year experience at the Tel Aviv Medical Center in 508 patients. Isr Med Assoc J (2007) 0.91
Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma. Eur J Haematol (2007) 0.91
Red blood cell distribution width and 3-year outcome in patients undergoing cardiac catheterization. J Thromb Thrombolysis (2014) 0.90
Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis (2009) 0.90
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Br J Haematol (2013) 0.89
Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol (2010) 0.89
Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men. Eur J Endocrinol (2009) 0.89
Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol (2009) 0.89
Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med (2004) 0.88
Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J (2005) 0.88
Vitamin D deficiency prevalence and cardiovascular risk in Israel. Eur J Clin Invest (2010) 0.88